Literature DB >> 32003735

Efficacy of a novel oral appliance and the role of posture on nasal resistance in obstructive sleep apnea.

Benjamin K Tong1,2, Carolin Tran1, Andrea Ricciardiello1, Alan Chiang1, Michelle Donegan1, Nick Murray3, Irene Szollosi4, Jason Amatoury1,2,5, Jayne C Carberry1,2,6, Danny J Eckert1,2,6.   

Abstract

STUDY
OBJECTIVES: High nasal resistance is associated with oral appliance treatment failure in obstructive sleep apnea (OSA). A novel oral appliance with a built-in oral airway has been shown to reduce pharyngeal pressure swings during sleep and may be efficacious in those with high nasal resistance. The role of posture and mandibular advancement on nasal resistance in OSA remains unclear. This study aimed to determine (1) the effects of posture and mandibular advancement on nasal resistance in OSA and (2) the efficacy of a new oral appliance device including in patients with high nasal resistance.
METHODS: A total of 39 people with OSA (7 females, apnea-hypopnea index (AHI) (mean ± standard deviation) = 29 ± 21 events/h) completed split-night polysomnography with and without oral appliance (order randomized). Prior to sleep, participants were instrumented with a nasal mask, pneumotachograph, and a choanal pressure catheter for gold standard nasal resistance quantification seated, supine and lateral (with and without oral appliance, order randomized).
RESULTS: Awake nasal resistance increased from seated, to supine, to lateral posture (median [interquartile range] = 1.8 [1.4, 2.7], 2.7 [1.7, 3.5], 3.4 [1.9, 4.6] cm H₂O/L/s, P < .001). Corresponding measures of nasal resistance did not change with mandibular advancement (2.3 [1.4, 3.5], 2.5 [1.8, 3.6], 3.5 [1.9, 4.8] cm H₂O/L/s, P = .388). The median AHI reduced by 47% with oral appliance therapy (29 ± 21 versus 18 ± 15 events/h, P = .002). Participants with high nasal resistance (> 3 cm H₂O/L/s) had similar reductions in AHI versus those with normal nasal resistance (61 [-8, 82] versus 40 [-5, 62] %, P = .244).
CONCLUSIONS: Nasal resistance changes with posture in people with OSA. A novel oral appliance with a built-in oral airway reduces OSA severity in people with OSA, including in those with high nasal resistance. CLINICAL TRIAL REGISTRATION: Registry: ANZCTR; Title: Combination therapy for obstructive sleep apnoea; Identifier: ACTRN12617000492358; URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372279.
© 2020 American Academy of Sleep Medicine.

Entities:  

Keywords:  lung; mandibular advancement therapy; sleep-disordered breathing; upper airway physiology

Year:  2020        PMID: 32003735      PMCID: PMC7161450          DOI: 10.5664/jcsm.8244

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  47 in total

1.  Determinants of Objective Compliance During Oral Appliance Therapy in Patients With Sleep-Disordered Breathing: A Prospective Clinical Trial.

Authors:  Marijke Dieltjens; Annelies E Verbruggen; Marc J Braem; Kristien Wouters; Johan A Verbraecken; Wilfried A De Backer; Evert Hamans; Paul H Van de Heyning; Olivier M Vanderveken
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-10       Impact factor: 6.223

2.  Rapid eye movement-related disordered breathing: clinical and polysomnographic features.

Authors:  José Haba-Rubio; Jean-Paul Janssens; Thierry Rochat; Emilia Sforza
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

3.  Reciprocal changes in nasal resistance in response to changes in posture.

Authors:  F D Babatola
Journal:  Rhinology       Date:  1998-06       Impact factor: 3.681

4.  The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea.

Authors:  Sushanth Bhat; Divya Gupta; Omar Akel; Peter G Polos; Vincent A DeBari; Shaista Akhtar; Anna McIntyre; Sue X Ming; Hinesh Upadhyay; Sudhansu Chokroverty
Journal:  Sleep Med       Date:  2018-07-04       Impact factor: 3.492

5.  Prospective study of the association between sleep-disordered breathing and hypertension.

Authors:  P E Peppard; T Young; M Palta; J Skatrud
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

6.  Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial.

Authors:  Lourdes Lozano; José Luis Tovar; Gabriel Sampol; Odile Romero; María José Jurado; Alfons Segarra; Eugènia Espinel; José Ríos; María Dolores Untoria; Patrícia Lloberes
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

7.  Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

8.  Obstructive sleep apnea as a risk factor for stroke and death.

Authors:  H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

Review 9.  Oral appliance treatment for obstructive sleep apnea: an update.

Authors:  Kate Sutherland; Olivier M Vanderveken; Hiroko Tsuda; Marie Marklund; Frederic Gagnadoux; Clete A Kushida; Peter A Cistulli
Journal:  J Clin Sleep Med       Date:  2014-02-15       Impact factor: 4.062

10.  An automated and reliable method for breath detection during variable mask pressures in awake and sleeping humans.

Authors:  Chinh D Nguyen; Jason Amatoury; Jayne C Carberry; Danny J Eckert
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

View more
  3 in total

1.  Influence of postural changes on nasal resistance in patients with obstructive sleep apnea.

Authors:  Yunhan Shi; Hongfei Lou; Huijun Wang; Yi Zhou; Li Wang; Yanru Li; Demin Han
Journal:  Sleep Breath       Date:  2022-08-03       Impact factor: 2.655

2.  Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.

Authors:  Atqiya Aishah; Richard Lim; Scott A Sands; Luigi Taranto-Montemurro; Andrew Wellman; Jayne C Carberry; Danny J Eckert
Journal:  J Appl Physiol (1985)       Date:  2021-03-18

3.  Comparative evaluation of the efficacy of customized maxillary oral appliance with mandibular advancement appliance as a treatment modality for moderate obstructive sleep apnea patients-protocol for a randomized controlled trial.

Authors:  Vikram Belkhode; Surekha Godbole; Sharayu Nimonkar; Pranali Nimonkar; Sweta Pisulkar
Journal:  Trials       Date:  2022-02-16       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.